Starling Oncology (STLN) Net Cash Flow Growth (3y) (2023 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.73 Bn | 89.71 Bn | 15.19 Bn | 54.67% |
| 2 | Tenet Healthcare | 22.05 Bn | 19.88 Bn | 4.45 Bn | -88.93% |
| 3 | Encompass Health | 12.13 Bn | 12.00 Bn | 1.34 Bn | -41.97% |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 60.86% |
| 5 | Universal Health Services | 10.12 Bn | 9.98 Bn | 3.29 Bn | 38.26% |
| 6 | Ensign | 9.97 Bn | 9.64 Bn | 306.24 Mn | -70.77% |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | -38.79% |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn | -21.23% |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn | - |
| 10 | Starling Oncology | 613.55 Mn | 572.46 Mn | 27.17 Mn | -7.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -7.45% |
| Mar 31, 2026 | -66.90% |
| Dec 31, 2025 | 28.56% |
| Sep 30, 2025 | 1.82% |
| Jun 30, 2025 | 32.94% |
| Mar 31, 2025 | 20.33% |
| Dec 31, 2024 | -72.82% |
| Sep 30, 2024 | 71.21% |
| Jun 30, 2024 | 26.62% |
| Mar 31, 2024 | -50.69% |
| Dec 31, 2023 | 32.17% |
| Sep 30, 2023 | -135.02% |
| Jun 30, 2023 | 229.40% |